TerrAscend's Q3 Net Revenue And Adj. EBITDA Increased 24% And 89%, Respectively

fan of 100 U.S. dollar banknotes

Image Source: Unsplash
 

TerrAscend (TSNDF) reported its financial and operating results for the third quarter ended September 30, 2023, today. All financial information is provided in U.S. dollars unless otherwise indicated and compared with the previous quarter.
 

Q3 Financial Highlights

  • Net Revenue: UP for 8th consecutive quarter by 23.7% to $89.2M
  • Gross Profit: UP 32.0% to $47.8M
    • Gross Profit Margin: UP to 53.6% from 50.2%
  • Gen. & Admin. Exp.: DOWN 3.9% to $29.3M
    • as a % of Net Revenue: DOWN  to 32.8% from 42.3%
  • Adj. EBITDA: UP 89.1% to $24.2M
    • Adj. EBITDA Margin: UP to 27.1% from 17.8%
  • Net Income (Loss): DOWN 34.9% to $(8.4)M
  • Cash/Equiv. + Restricted): DOWN 17.4% to $28.5M
     

Q3 Business & Operational Highlights

  • Improved to #2 position in New Jersey, with 18.6% market share, and is closing in on the #1 position of 18.8%, according to BDSA for September 2023.
  • Commenced adult-use sales in Maryland with four retail dispensaries and a state-of-the-art cultivation facility.
  • Launched Wana brand into the Maryland market.
  • Improved gross margin in Michigan by 800-basis points sequentially to 36% in Q3 and exited the quarter at 40% in September.
  • Returned to retail and wholesale growth in Pennsylvania both year-over-year and sequentially.
  • Commenced trading on the Toronto Stock Exchange (“TSX”) under the symbol ‘TSND’ on July 4, 2023.
     

Outlook for 2023

  • The Company is raising its outlook for Net Revenue and Adjusted EBITDA from continuing operations for 2023 to $320 million and $73 million, respectively, representing year-over-year growth of 29% in Net Revenue and 87% in Adjusted EBITDA from continuing operations, respectively.  
  • The full year 2023 increase in guidance implies 2023 fourth quarter Net Revenue of $89 million and Adjusted EBITDA from continuing operations of $24 million.
     

Stock Performance

TerrAscend's stock price had climbed by 86.4% as of the end of Q3 but has declined by 21.5% since then but remains UP 44.9% YTD.


More By This Author:

Aurora Cannabis' Q2 Net Income Was Positive For The First Time
Humane's Ai Pin Being Launched Later Today: An Update
Trulieve Cannabis Q3 Financials Show Major Improvement In Net Loss

Disclosure: None

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.